<DOC>
	<DOCNO>NCT01309139</DOCNO>
	<brief_summary>The primary objective compare systemic exposure tiotropium CD 1857 treatment fix dose combination ( fix dose combination ( FDC ) , Treatment A ) tiotropium plus BI 54903 ( ethanolic solution inhalation ( EIS ) , Respimat ( RMT ) B ) systemic exposure follow inhalation free combination ( Treatment B ) tiotropium ( aqueous solution inhalation ( AIS ) , RMT A ) plus BI 54903 ( EIS , RMT B ) , administer once-daily 21 day via Respimat ( R ) ( RMT ) . The secondary objective : compare systemic exposure tiotropium CD 1857 single dose administration FDC free combination tiotropium/BI 54903 compare systemic exposure BI 54903 single dose steady state multiple dos FDC free combination tiotropium/BI 54903 compare safety tolerability tiotropium BI 54903 administer FDC free dose combination , respectively</brief_summary>
	<brief_title>Pharmacokinetics Fixed Dose Combination Tiotropium Plus BI 54903 Versus Combination Monoproducts Tiotropium BI 54903 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male female accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead electrocardiogram ( ECG ) , clinical laboratory test . 2 . Age 21 50 year . Exclusion criterion : 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . History evidence relevant psychiatric disorder neurological disorder 5 . History evidence relevant autonomic dysfunction ( orthostatic hypotension , faint spell blackout ) 6 . Chronic relevant acute infection 7 . History relevant allergy/hypersensitivity ( include allergy drug excipients ) 8 . Intake prescription drug overthecounter ( counter ( OTC ) ) medication ( vitamin , herbal supplement , dietary supplement ) long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial 9 . Participation another trial investigational drug within two month prior administration trial 10 . Smoker ( 10 cigarette daily )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>